Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclooxygenase 2 and the kidney.

M D Breyer1, R C Harris

  • 1Department of Medicine, Veterans Administration Medical Center and Vanderbilt University, Nashville, Tennessee, USA. matthew.breyer@mcmail.vanderbilt.edu

Current Opinion in Nephrology and Hypertension
|February 24, 2001
PubMed
Summary

Cyclooxygenase-2 (COX2) selective drugs, while sparing the gut, can harm the kidney. Renal effects of NSAIDs are primarily mediated by COX2 inhibition, necessitating caution with COX2-selective inhibitors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does Malfunction of Arachidonic Acid Epoxygenase Explain Salt-Sensitive Hypertension?: Salt-Sensitive Hypertension Is Associated with Dysfunctional Cyp4a10 Gene and Kidney Epithelial Sodium Channel. J Clin Invest 116: 1696-1702, 2006.

Journal of the American Society of Nephrology : JASN·2023
Same author

New tuberculosis vaccines: advances in clinical development and modelling.

Journal of internal medicine·2020
Same author

Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry.

Vaccine·2020
Same author

A Novel Aldosterone Antagonist Limits Renal Injury in 5/6 Nephrectomy.

Scientific reports·2017
Same author

The novel adipokine/hepatokine fetuin B in severe human and murine diabetic kidney disease.

Diabetes & metabolism·2017
Same author

Stress and coping in fourth-year medical and dental students.

The New Zealand dental journal·2015

Area of Science:

  • Nephrology
  • Pharmacology
  • Biochemistry

Background:

  • Cyclooxygenase (COX) enzymes metabolize arachidonic acid into prostaglandins.
  • Two isoforms, COX1 and COX2, exist with distinct kidney expression patterns.
  • COX2 expression is dynamically regulated by physiological and environmental factors.

Purpose of the Study:

  • To elucidate the differential roles of COX1 and COX2 in renal function.
  • To understand the renal implications of COX2-selective non-steroidal anti-inflammatory drugs (NSAIDs).

Main Methods:

  • Review of existing literature on COX isoforms and NSAID pharmacology.
  • Analysis of the localization and regulation of COX1 and COX2 in renal tissues.
  • Examination of the mechanisms underlying NSAID-induced renal effects.

Related Experiment Videos

Main Results:

  • COX1 is predominantly found in vascular smooth muscle and collecting ducts.
  • COX2 is highly expressed in the macula densa, cortical thick ascending limb, and medullary interstitial cells.
  • Inhibition of COX2, not COX1, appears to mediate many renal adverse effects of NSAIDs, including sodium retention and reduced glomerular filtration rate.

Conclusions:

  • COX2 plays a critical role in regulating renal hemodynamics and salt balance.
  • COX2-selective NSAIDs carry significant renal risks comparable to traditional non-selective NSAIDs.
  • Caution is advised when prescribing COX2-selective inhibitors due to potential nephrotoxicity.